You probably think TB is a disease of the past. But that’s not because we’ve beat it. It’s because we’ve moved it elsewhere. Every year, over 10 million people fall ill with tuberculosis and it's concentrated where people are poorest, where overcrowding helps it spread, and where a six-month treatment course can mean losing your job, or even your social life.  Professor Greg Fox is an infectious diseases physician who treats TB patients in Sydney and leads research across Southeast Asia.   Greg outlines Australia’s responsibility to its neighbours in battling TB, and explains why cultural barriers like stigma make treatment so difficult in countries like Vietnam.   Read more about tuberculosis in Everything is Tuberculosis by John Green. +++  The Solutionists is a podcast from the University of Sydney, produced by Deadset Studios. This episode was produced by Liam Riordan with sound design by Jeremy Wilmot. Supervising producer is Sarah Dabro. Executive editors are Kellie Riordan, Jen Peterson-Ward, and Mark Scott. Strategist is Ann Chesterman.  This podcast was recorded on the land of the Gadigal people of the Eora nation. For thousands of years, across innumerable generations, knowledge has been taught, shared and exchanged here. We pay respect to elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people.

Ending TB is within our reach, if we act together. Partners around the world are showing what collective action can achieve. #WorldTBDay #shorts

Respiratory physician and epidemiologist Professor Guy Marks explains why tuberculosis remains a major public health challenge, but also an opportunity. With today’s screening, diagnostic, and treatment tools, ending TB is possible if we choose to prioritise it.

Professor Steve Graham introduces the online course on the management of child and adolescent TB, available for free on the Union Online Courses platform. The course also includes a package of training resources designed for use in low‑ and middle‑income countries that want to deliver national or sub‑national courses to build the skills of clinicians in identifying child TB. https://coursesonline.theunion.org/theunion/?menu=25&browseby=9&trend=19469&featured=18155&sortby=1#!*menu=25*browseby=9*sortby=1*trend=19469*featured=18155

TB remains the leading infectious killer on the planet. A disease thousands of years old, with a cure, still claiming a life every 20 seconds Every day across the University of Sydney our world-leading researchers are working to protect communities here in Australia, and across our region against TB. At the University of Sydney, our partnerships, our science, and our people are united to end TB.

Prof Warwick Britton's welcome address to the TB-CRE 2021 Symposium. The NHMRC Centre of Research Excellence in Tuberculosis Control (TB-CRE) is a research collaboration centre that develops, tests, and implements tuberculosis elimination strategies in Australia and the Asia-pacific region. Website: https://www.tbcre.org.au/ Twitter: https://twitter.com/Control_TB

Dr Thu Anh Nguyen presents an update on ACT5 - a randomised cluster trial to reduce the prevalence of TB among adults in the general community in Vietnam. 26 May 2021 - TB-CRE 2021 Symposium https://www.tbcre.org.au/

Dr Amanda Christensen and Dr Mikaela Coleman present the PEARL study at the TBCRE 2021 Symposium (27 May 2021). https://www.tbcre.org.au/ "The study, Pathway to the Elimination of Antibiotic Resistant and Latent tuberculosis in the Pacific (PEARL), will screen every person aged 3 & older in a population of more that 60,000 people in South Tarawa. Each person will be tested for TB disease or infection by tuberculin skin testing, chest X-ray and/or sputum testing. People with active TB will be referred for TB treatment, and those with LTBI will be treated with preventative therapy to diminish the pool of future disease activation. The PEARL study utilises concepts of whole population screening and active case finding, which was shown by TB-CRE researchers and PEARL study researchers Professor Guy Marks and Associate Professor Greg Fox to halve TB over 4 years in the Asia-Pacific context of Vietnam (the ACT5 trial). The wealth of expertise in TB control and elimination within the TB-CRE has been looked to in the development of this exciting study. The project, in collaboration with the Australian Respiratory Council (ARC) further incorporates capacity building and education in TB control for Kiribati and 6 other Pacific Island nations. Cost-effectiveness and strategy modelling for the improvement of TB elimination studies will be included by study colleagues working in Melbourne at Monash University under the leadership of Associate Professor James Trauer. The research is being funded under the Medical Research Future Fund’s Global Health Initiative, which focuses on AMR and DR-TB as threats to global and national health security. " https://www.tbcre.org.au/post/4-25-million-for-tb-control-in-the-pacific

Prof Greg Fox presented new models of care to reduce TB mortality and improve outcomes. (27 May 2021) TB-CRE 2021 Symposium. https://www.tbcre.org.au/